(4-cyclopropyl-2,3-difluorophenyl)-[(2R)-2-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)morpholin-4-yl]methanone
C20H19F2N5O2 — CID 118479721
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4-cyclopropyl-2,3-difluorophenyl)-[(2R)-2-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)morpholin-4-yl]methanone
(4-cyclopropyl-2,3-difluorophenyl)-[(2R)-2-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)morpholin-4-yl]methanone (PubChem CID 118479721) has the molecular formula C20H19F2N5O2 and a molecular weight of 399.40 g/mol. Its IUPAC name is (4-cyclopropyl-2,3-difluorophenyl)-[(2R)-2-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)morpholin-4-yl]methanone.
Molecular Properties
| Compound Name | (4-cyclopropyl-2,3-difluorophenyl)-[(2R)-2-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)morpholin-4-yl]methanone |
|---|---|
| PubChem CID | 118479721 |
| Molecular Formula | C20H19F2N5O2 |
| Molecular Weight | 399.40 g/mol |
| Exact Mass | 399.15 |
| IUPAC Name | (4-cyclopropyl-2,3-difluorophenyl)-[(2R)-2-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)morpholin-4-yl]methanone |
| SMILES | Cc1cc([C@H]2CN(C(=O)c3ccc(C4CC4)c(F)c3F)CCO2)n2ncnc2n1 |
| InChI | InChI=1S/C20H19F2N5O2/c1-11-8-15(27-20(25-11)23-10-24-27)16-9-26(6-7-29-16)19(28)14-5-4-13(12-2-3-12)17(21)18(14)22/h4-5,8,10,12,16H,2-3,6-7,9H2,1H3/t16-/m1/s1 |
| InChIKey | QLEWKWWBZMDFRB-MRXNPFEDSA-N |
| XLogP | 2.80 |
| TPSA | 72.62 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 399.40 |
| LogP ≤ 5 | 2.80 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118479721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.